Addition of phenylephrine to high-dose insulin in dihydropyridine overdose does not improve outcome

References

• Bronstein AC, Spyker DA, Cantilena JR, Green JL, Rumack BH, Giffin SL. 2008 Annual report of the American Association of Poison Control Centers National Poison Data System (NPDS): 26th annual report. Clin Toxicol 2009; 47:914–1084.
   Web of Science ®Google Scholar
• Schoffstall JM, Spivey WH, Gambone LM, Shaw RP, Sit SP. Effects of calcium channel blocker overdose-induced toxicity in the conscious dog. Ann Emerg Med 1991; 20:1104–1108.
   PubMed Web of Science ®Google Scholar
• Shepherd G. High dose insulin therapy for calcium channel blocker overdose. Ann Pharmacother 2005; 39:923–930.
   PubMed Web of Science ®Google Scholar
• Anderson EA, Hoffman RP, Valon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 1991; 87:2246–2252.
   PubMed Web of Science ®Google Scholar
• Crystal GJ, Kim GJ, Ramez Salem M, Abdel-Latif, M. Myocardial oxygen supply/demand relations during phenylephrine infusions in dogs. Anesth Analg 1991; 73:284–288.
   Google Scholar
• Holger JS, Dries DJ, Barringer KW, Peake BJ, Flottemesch TJ, Marini JJ. Cardiovascular and metabolic effects of high-dose insulin in a porcine septic shock model. Acad Emerg Med 2010; 17:429–435.
   PubMed Web of Science ®Google Scholar
• Pocock SJ. Group sequential methods in the design and analysis of clinical trials. Biometrika 1977; 64:191–199.
   Web of Science ®Google Scholar
• Megarbane B, Karyo S, Baud FJ. The role of insulin and glucose (hyperinsulinaemia/euglycaemia) therapy in acute calcium channel antagonist and β-blocker poisoning. Toxicol Rev 2004; 23:215–222.
   PubMedGoogle Scholar
• Salhanick SD, Shannon MW. Management of calcium channel antagonist overdose. Drug Saf 2003; 26:65–79.
   PubMed Web of Science ®Google Scholar
• Kerns II W, Shroeder D, Williams C, Tomaszewski C, Raymond R. Insulin improves survival in a canine model of acute beta blocker toxicity. Ann Emerg Med 1997; 29:748–757.
   PubMed Web of Science ®Google Scholar
• Kline JA, Leonova E, Raymond R. Beneficial myocardial metabolic effects of insulin during verapamil toxicity in the anesthetized canine. Crit Care Med 1995; 23:1251–1263.
   PubMed Web of Science ®Google Scholar
• Kline JA, Raymond RM, Leonova ED, Williams TC, Watts JA. Insulin improves heart function and metabolism during non-ischemic cardiogenic shock in awake canines. Cardiovascular Research 1997; 34:289–298.
   PubMed Web of Science ®Google Scholar
• Stone CK, Thomas SH, Koury SI, Low RB. Glucagon and phenylephrine combination versus glucagon alone in experimental verapamil overdose. Acad Emerg Med 1996; 3:12–125.
   Google Scholar
• Holger JS, Engebretsen, KM, Fritzlar SJ, Patten LC, Harris CR, Flottemesch TJ. Insulin versus vasopressin and epinephrine to treat beta-blocker toxicity. Clin Toxicol 2007; 45:396–401.
   PubMed Web of Science ®Google Scholar
• Svedjeholm R, Hallhagen S, Ekroth R, Joachimsson PO, Ronquist G. Dopamine and high dose insulin infusion (glucose-insulin-potassium) after a cardiac operation: Effects on myocardial metabolism. Ann Thorac Surg 1991; 51:262–270.
   PubMed Web of Science ®Google Scholar
• Bersin RM, Stacpoole PW. Dichloroacetate as metabolic therapy for myocardial ischemia and failure. Am Heart J 1997; 134(5 Pt 1):841–855.
   PubMed Web of Science ®Google Scholar
• De Backer D, Creteur J, Dubois MJ, Sakr Y, Vincent JL. Microvascular alterations in patients with acute severe heart failure and cardiogenic shock. Am Heart J 2004;147:91–99.
   PubMed Web of Science ®Google Scholar
• Bellomo R, Wam L, May C. Vasoactive drugs and acute kidney injury. Crit Care Med 2008; 36:S179–S186.
   PubMed Web of Science ®Google Scholar
• Clerk LH, Vincent MA, Lindner JR, Clark MG, Rattigan S, Barrett E. The vasodilatory actions of insulin on resistance and terminal arterioles and their impact on muscle glucose uptake. Diabetes Metab Res Rev 2004; 20:3–12.
   PubMed Web of Science ®Google Scholar
• Leppikangas H, Ruokonen E, Rutanen J, Kivinemi V, Lindgren L, Kurola J. Levosimendan as a rescue drug in experimental propranolol-induced myocardial depression: A randomized study. Ann Emerg Med 2009; 54:811–817.
   PubMed Web of Science ®Google Scholar
• Jamatay C, Bailey B, Larocque A, Notebaert E, Sanogo K, Chauny JM. Lipid emulsions in the treatment of acute poisoning: A systematic review of human and animal studies. Clin Toxicol 2010; 48:1–27.
   Web of Science ®Google Scholar
• Bania T, Chu J, Perez E, Medlej K, Rosselli M, Mouravev R, Yang J, Lee D. Hemodynamic effects of intravenous fat emulsion versus high dose insulin euglycemia in a model of severe verapamil toxicity. Acad Emerg Med 2008; 15(5 Suppl. 1):S93.
   Google Scholar
• Chu J, Medlej K, Bania T, Perez E, Mouravev R. The effect of intravenous fat emulsions in nifedipine toxicity. Acad Emerg Med 2009; 16:S226.
   PubMed Web of Science ®Google Scholar